On Friday, March 27, 2020, it was signed into law by the President after receiving bipartisan support in both the House and Senate. The CARES Act is the third large-scale Congressional effort in response to the novel coronavirus (COVID-19) pandemic.
The legislation provides a number of provisions to provide financial relief and resources to individuals, families and businesses particularly hard hit by the COVID-19 pandemic. It also includes a number of important provisions directly related to health care, including mental health and telehealth, and veterans.
Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.